Education
About Us
Working with TipRanks
Follow Us
CervoMed (CRVO)
NASDAQ:CRVO
Total Valuation
CervoMed has a market cap or net worth of $73.71M. The enterprise value is $80.40M.
Market Cap$73.71M
Enterprise Value$80.40M
Share Statistics
CervoMed has 8.70M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding8.70M
Owened by Insiders48.27%
Owened by Instutions1.97%
Financial Efficiency
CervoMed’s return on equity (ROE) is -0.42 and return on invested capital (ROIC) is -46.50%.
Return on Equity (ROE)-41.56%
Return on Assets (ROA)-37.81%
Return on Invested Capital (ROIC)-46.50%
Return on Capital Employed (ROCE)-46.50%
Revenue Per Employee$375,748.067
Profits Per Employee-$1,086,046.333
Employee Count15
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of CervoMed is -1.16. CervoMed’s PEG ratio is >-0.01.
PE Ratio-1.16
PS Ratio0.00
PB Ratio0.48
Price to Fair Value0.48
Price to FCF-1.14
Price to Operating Cash Flow-1.14
PEG Ratio>-0.01
Income Statement
In the last 12 months, CervoMed had revenue of $5.64M and earned -$16.29M in profits. Earnings per share was -$1.78.
Revenue$5.64M
Gross Profit$2.82M
Operating Income-$18.23M
Pretax Income-$16.29M
Net Income-$16.29M
EBITDA-18.23M
Earnings Per Share (EPS)-1.78
Cash Flow
In the last 12 months, operating cash flow was -$19.77M and capital expenditures $0.00, giving a free cash flow of -$19.77M billion.
Operating Cash Flow-$19.77M
Free Cash Flow-$19.77M
Free Cash Flow per Share-$2.27
Dividends & Yields
CervoMed pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-87.51%
Earnings Yield-86.23%
Stock Price Statistics
Beta-0.03
52-Week Price Change-63.60%
50-Day Moving Average5.53
200-Day Moving Average9.93
Relative Strength Index (RSI)62.10
Average Volume (3m)9.49M
Important Dates
CervoMed upcoming earnings date is May 14, 2025, Before Open.
Last Earnings DateApr 7, 2025
Next Earnings DateMay 14, 2025
Ex-Dividend Date―
Financial Position
CervoMed as a current ratio of 11.11, with Debt / Equity ratio of 0.00
Current Ratio11.11
Quick Ratio11.11
Debt to Market Cap0.00
Net Debt to EBITDA0.49
Interest Coverage Ratio0.00
Taxes
In the past 12 months, CervoMed has paid $2.00 in taxes.
Income Tax$2.00
Effective Tax Rate0.00%
Enterprise Valuation
CervoMed EV to EBITDA ratio is -0.54, with an EV/FCF ratio of -0.60.
EV to Sales0.00
EV to EBITDA-0.54
EV to Free Cash Flow-0.60
EV to Operating Cash Flow-0.60
Balance Sheet
CervoMed has $38.92M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$38.92M billion.
Cash & Marketable Securities$38.92M
Total Debt$0.00
Net Cash-$38.92M
Net Cash Per Share-$4.47
Tangible Book Value Per Share$4.86
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for CervoMed is $15.83, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$15.83
Price Target Upside86.24%
Analyst ConsensusStrong Buy
Analyst Count6
Revenue Growth Forecast142.42%
EPS Growth Forecast53.38%